Recro Pharma (NASDAQ:REPH) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Recro Pharma beat estimated earnings by 42.86%, reporting an EPS of $-0.04 versus an estimate of $-0.07.
Revenue was up $12.39 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 9.57% drop in the share price the next day.
Here's a look at Recro Pharma's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.11 | -0.25 | -0.25 |
| EPS Actual | -0.07 | 0.03 | -0.23 | -0.48 |
| Revenue Estimate | 18.07M | 17.10M | 16.43M | 15.00M |
| Revenue Actual | 18.24M | 18.02M | 16.80M | 9.91M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.